ACE and heart failure: However, in the late cohort, more patients were treated with ACE-inhibitors/angiotensin receptor blockers, calcium channel blockers and oral anticoagulants (Table 2), which could suggest an overall better management of hypertension, heart failure and atrial fibrillation.